Cang-Ai Volatile Oil Mitigates Lipopolysaccharide-Induced Depressive-Like Behaviour in Mice by Modulating the Microglial BDNF/CREB Signaling Pathway
Open Access
- 27 November 2025
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 188
Abstract
Depression is a severe mental disorder with evidence suggesting that microglial modulation can play a crucial role in elevating brain-derived neurotrophic factor (BDNF) level in hippocampus. Previous studies highlight that Cang-ai volatile oil (CAVO) exhibits antidepressant effects by inhibiting microglial activation and neuroinflammation while upregulating BDNF expression. This study aimed to investigate CAVO's antidepressant effects through modulating microglial phenotypic polarization and the BDNF/cAMP response element binding protein (CREB) pathway. Results showed that in a Lipopolysaccharide (LPS)-induced depression model, CAVO increased the animals' body weight (BW) and alleviated depressive-like behaviors. CAVO reduced the number of Iba1 and CD16/32 co-localized cells and decreased pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), while increasing IL-4, IL-10, and BDNF levels. In LPS-activated BV2 cells, CAVO reversed the elevated release of pro-inflammatory cytokines and enhanced anti-inflammatory factors, demonstrating a dose-dependent response. Additionally, CAVO treatment significantly elevated CD163 expression while reducing CD86 expression, with the most prominent effects observed at the higher CAVO dose, indicating the potential of CAVO to modulate microglial polarization from an M1 pro-inflammatory state towards an M2 anti-inflammatory phenotype. Western blot analysis confirmed that CAVO elevated BDNF, AKT, and p-CREB while reducing ERK1/2 expression in both mouse and BV2 cells. The findings support the therapeutic potential of CAVO in depression treatment through modulation of inflammatory responses and enhancement of BDNF synthesis via the BDNF/CREB pathway in microglia.Keywords
Funding Information
- National Natural Science Foundation of China (82074421, 82060823)
- Natural Science Foundation of Yunnan Province (202103AC100005, 2017FA045)
- Yunnan Key Laboratory of Formulated Granules (202105AG070014)
This publication has 43 references indexed in Scilit:
- Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depressionBehavioural Brain Research, 2019
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress ModelBiological Psychiatry, 2018
- Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controlsPsychiatry Research, 2017
- The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal CortexNeural Plasticity, 2017
- Depression as a Microglial DiseaseTrends in Neurosciences, 2015
- Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric diseaseNature Reviews Neuroscience, 2014
- Microglial polarization and plasticity: Evidence from organotypic hippocampal slice culturesGlia, 2013
- Microglia Control Neuronal Network Excitability via BDNF SignallingNeural Plasticity, 2013
- Depression, chronic diseases, and decrements in health: results from the World Health SurveysThe Lancet, 2007
- The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in miceNeuroscience & Biobehavioral Reviews, 2005